These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 8772579

  • 1. Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5 alpha-pregnane-3,20-dione and 3 alpha-hydroxy-5 alpha-pregnan-20-one.
    Wang M, Seippel L, Purdy RH, Bãckström T.
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1076-82. PubMed ID: 8772579
    [Abstract] [Full Text] [Related]

  • 2. Relationship between symptom severity and hormone changes in women with premenstrual syndrome.
    Hammarbäck S, Damber JE, Bäckström T.
    J Clin Endocrinol Metab; 1989 Jan; 68(1):125-30. PubMed ID: 2491857
    [Abstract] [Full Text] [Related]

  • 3. [Correlation between neurotransmitters and neurosteroids and premenstrual syndrome patients of Gan-yang ascending syndrome and Gan-qi stagnation syndrome].
    Gao H, Xia T, Qiao MQ.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Nov; 32(11):1503-7. PubMed ID: 23359974
    [Abstract] [Full Text] [Related]

  • 4. Luteal-phase estradiol relates to symptom severity in patients with premenstrual syndrome.
    Seippel L, Bäckström T.
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1988-92. PubMed ID: 9626129
    [Abstract] [Full Text] [Related]

  • 5. Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects.
    Schmidt PJ, Purdy RH, Moore PH, Paul SM, Rubinow DR.
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1256-60. PubMed ID: 7962316
    [Abstract] [Full Text] [Related]

  • 6. Adrenal response to adrenocorticotropic hormone stimulation in patients with premenstrual syndrome.
    Lombardi I, Luisi S, Quirici B, Monteleone P, Bernardi F, Liut M, Casarosa E, Palumbo M, Petraglia F, Genazzani AR.
    Gynecol Endocrinol; 2004 Feb; 18(2):79-87. PubMed ID: 15195499
    [Abstract] [Full Text] [Related]

  • 7. Brain-derived neurotrophic factor plasma variation during the different phases of the menstrual cycle in women with premenstrual syndrome.
    Cubeddu A, Bucci F, Giannini A, Russo M, Daino D, Russo N, Merlini S, Pluchino N, Valentino V, Casarosa E, Luisi S, Genazzani AR.
    Psychoneuroendocrinology; 2011 May; 36(4):523-30. PubMed ID: 20933336
    [Abstract] [Full Text] [Related]

  • 8. Cerebrospinal fluid levels of monoamine metabolites. A preliminary study of their relation to menstrual cycle phase, sex steroids, and pituitary hormones in healthy women and in women with premenstrual syndrome.
    Eriksson E, Alling C, Andersch B, Andersson K, Berggren U.
    Neuropsychopharmacology; 1994 Nov; 11(3):201-13. PubMed ID: 7532413
    [Abstract] [Full Text] [Related]

  • 9. Allopregnanolone concentrations and premenstrual syndrome.
    Monteleone P, Luisi S, Tonetti A, Bernardi F, Genazzani AD, Luisi M, Petraglia F, Genazzani AR.
    Eur J Endocrinol; 2000 Mar; 142(3):269-73. PubMed ID: 10700721
    [Abstract] [Full Text] [Related]

  • 10. Lack of plasma norepinephrine cyclicity, increased estradiol during the follicular phase, and of progesterone and gonadotrophins at ovulation in women with premenstrual syndrome.
    Blum I, Lerman M, Misrachi I, Nordenberg Y, Grosskopf I, Weizman A, Levy-Schiff R, Sulkes J, Vered Y.
    Neuropsychobiology; 2004 Mar; 50(1):10-5. PubMed ID: 15179014
    [Abstract] [Full Text] [Related]

  • 11. Concentrations of progesterone and the 5 alpha-reduced progestins, 5 alpha-pregnane-3,20-dione and 3 alpha-hydroxy-5 alpha-pregnan-20-one, in luteal tissue and circulating blood and their relationship to luteal function in the African elephant, Loxodonta africana.
    Hodges JK, Heistermann M, Beard A, van Aarde RJ.
    Biol Reprod; 1997 Mar; 56(3):640-6. PubMed ID: 9047008
    [Abstract] [Full Text] [Related]

  • 12. Progesterone metabolite allopregnanolone in women with premenstrual syndrome.
    Rapkin AJ, Morgan M, Goldman L, Brann DW, Simone D, Mahesh VB.
    Obstet Gynecol; 1997 Nov; 90(5):709-14. PubMed ID: 9351749
    [Abstract] [Full Text] [Related]

  • 13. Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects.
    Sundström I, Andersson A, Nyberg S, Ashbrook D, Purdy RH, Bäckström T.
    Neuroendocrinology; 1998 Feb; 67(2):126-38. PubMed ID: 9508043
    [Abstract] [Full Text] [Related]

  • 14. Lack of effect of induced menses on symptoms in women with premenstrual syndrome.
    Schmidt PJ, Nieman LK, Grover GN, Muller KL, Merriam GR, Rubinow DR.
    N Engl J Med; 1991 Apr 25; 324(17):1174-9. PubMed ID: 2011161
    [Abstract] [Full Text] [Related]

  • 15. Menstrual cycle symptom variation in a community sample of women using and not using oral contraceptives.
    Sveinsdóttir H, Bäckström T.
    Acta Obstet Gynecol Scand; 2000 Sep 25; 79(9):757-64. PubMed ID: 10993099
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Association of inflammation markers with menstrual symptom severity and premenstrual syndrome in young women.
    Bertone-Johnson ER, Ronnenberg AG, Houghton SC, Nobles C, Zagarins SE, Takashima-Uebelhoer BB, Faraj JL, Whitcomb BW.
    Hum Reprod; 2014 Sep 25; 29(9):1987-94. PubMed ID: 25035435
    [Abstract] [Full Text] [Related]

  • 20. 5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder.
    Martinez PE, Rubinow DR, Nieman LK, Koziol DE, Morrow AL, Schiller CE, Cintron D, Thompson KD, Khine KK, Schmidt PJ.
    Neuropsychopharmacology; 2016 Mar 25; 41(4):1093-102. PubMed ID: 26272051
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.